Anthony Vecchione
The company will use the funds to drive product development, strategic account management and market growth.
The platform interprets patient responses into structured data and more efficiently finds responses that address patient needs like food insecurity or transportation barriers.
The company will use the funds to support people who are managing rare and complex conditions.
The aim is to reduce processing times, increase workflow and improve accuracy in medical records evaluations.
The hub expands the company's research and development footprint in the region and hastens the development of AI-powered digital health technologies.
The aim is to allow clinicians to transition between several therapeutic environments to optimize treatment outcomes.
The alliance will provide members with proactive, user-friendly remote monitoring capabilities.
The partnership will give AeroFlow customers access to DME prescriptions.
The company will use the funds to strengthen its research and development capabilities.
The aim of the acquisitions is to accelerate the company's involvement in two major growth areas and improve patient care.